| human | Q5 |
| P496 | ORCID iD | 0000-0001-9208-6523 |
| P1416 | affiliation | University of Washington Department of Laboratory Medicine and Pathology | Q99264783 |
| P166 | award received | Fellow of the American Heart Association | Q105670306 |
| Special Recognition Award in Vascular Biology | Q124980531 | ||
| P185 | doctoral student | Valerie Z. Wall | Q118213492 |
| P108 | employer | University of Washington | Q219563 |
| P735 | given name | Karin | Q1814118 |
| Karin | Q1814118 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject PCC Wikidata Pilot/University of Washington | Q98970039 |
| P21 | sex or gender | female | Q6581072 |
| Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
| Q50904472 | A Long Road Ahead for Discovering New HDL Metrics That Reflect Cardiovascular Disease Risk. |
| Q99593566 | A New Treatment Strategy for Diabetic Dyslipidemia? |
| Q52684469 | A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. |
| Q46350486 | A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis |
| Q89606407 | A Role of the Heme Degradation Pathway in Shaping Prostate Inflammatory Responses and Lipid Metabolism |
| Q79234273 | A single second messenger: several possible cellular responses depending on distinct subcellular pools |
| Q36742281 | Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages |
| Q39454322 | Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages |
| Q33724394 | Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity |
| Q35088381 | Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien |
| Q92045246 | Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus |
| Q33332589 | An inducible and reversible mouse genetic rescue system |
| Q90439211 | Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques |
| Q91116797 | Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein |
| Q104134617 | Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes |
| Q34342384 | Arterial smooth muscle |
| Q103799098 | Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes |
| Q36602802 | Atherosclerosis: Successes, Surprises, and Future Challenges |
| Q55265082 | Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity. |
| Q112736789 | Conformational flexibility of apolipoprotein A-I amino- and carboxy-termini is necessary for lipid binding but not cholesterol efflux |
| Q27334219 | Coordinate regulation of lipid metabolism by novel nuclear receptor partnerships |
| Q91717118 | Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity |
| Q43850804 | Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux |
| Q35204728 | Cyclic GMP phosphodiesterases and regulation of smooth muscle function |
| Q34113265 | Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation |
| Q38349580 | Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. |
| Q98579723 | Diabetes Impairs Cellular Cholesterol Efflux from ABCA1 to Small HDL Particles |
| Q37333371 | Diabetes and atherosclerosis: is there a role for hyperglycemia? |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q35849515 | Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. |
| Q33901965 | Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys |
| Q42964142 | Diabetes-accelerated atherosclerosis and inflammation |
| Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
| Q35672692 | Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes |
| Q36775094 | Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q35653968 | Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice |
| Q95317816 | Emerging Targets for Cardiovascular Disease Prevention in Diabetes |
| Q36558881 | Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment |
| Q42867693 | Evidence stacks up that endothelial insulin resistance is a culprit in atherosclerosis. |
| Q43152176 | GPIHBP1: two get tangled |
| Q30277854 | Genetic association of long-chain acyl-CoA synthetase 1 variants with fasting glucose, diabetes, and subclinical atherosclerosis |
| Q35860833 | Granulocyte/Macrophage Colony-stimulating Factor-dependent Dendritic Cells Restrain Lean Adipose Tissue Expansion |
| Q91584914 | Growing evidence for a role for acyl-CoA synthetase 1 in immunometabolism |
| Q93034636 | Hematopoietic Cell-Expressed Endothelial Nitric Oxide Protects the Liver From Insulin Resistance |
| Q90615969 | High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes |
| Q49789890 | High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus. |
| Q90757084 | Highlighting Residual Atherosclerotic Cardiovascular Disease Risk |
| Q93177836 | How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research |
| Q35212858 | How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion? |
| Q45161321 | Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. |
| Q98735051 | Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models |
| Q81164457 | IGF-I/insulin hybrid receptors in human endothelial cells |
| Q37149768 | Impact of Diabetes Mellitus |
| Q91795685 | Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes |
| Q38059912 | Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. |
| Q46381890 | Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (≥C20)-acyl chains in macrophages. |
| Q42854565 | Integrin alpha(7)beta(1) COMPels smooth muscle cells to maintain their quiescence |
| Q93177849 | Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis |
| Q26860086 | Lipids and the endothelium: bidirectional interactions |
| Q35140825 | Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes |
| Q50061471 | Liver Kinase B1 Links Macrophage Metabolism Sensing and Atherosclerosis |
| Q24337408 | Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells |
| Q55001106 | Long-term Western diet fed apolipoprotein E-deficient rats exhibit only modest early atherosclerotic characteristics. |
| Q36602809 | Macrophage Phenotype and Function in Different Stages of Atherosclerosis |
| Q34068374 | Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase |
| Q26796679 | Metabolic Flexibility and Dysfunction in Cardiovascular Cells |
| Q36371123 | Microvascular management of systemic insulin sensitivity |
| Q27332357 | Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q36766171 | Mouse models for studies of cardiovascular complications of type 1 diabetes |
| Q36063184 | Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes |
| Q89068457 | Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation |
| Q50102325 | Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor |
| Q38033682 | Novel insights into the role of S100A8/A9 in skin biology |
| Q83018858 | Nuclear signaling in smooth muscle cells: cyclic nucleotide phosphodiesterase 1A moves in |
| Q44077331 | Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells |
| Q33747946 | Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways |
| Q90539112 | Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease |
| Q92849110 | Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques" |
| Q28275533 | Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family |
| Q28573871 | Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes |
| Q33642252 | Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. |
| Q34769986 | S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation |
| Q37281416 | SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP. |
| Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
| Q91271562 | TNF-α induces acyl-CoA synthetase 3 to promote lipid droplet formation in human endothelial cells |
| Q33612986 | Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis |
| Q113757260 | The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease |
| Q73094488 | The cyclin-dependent kinase pathway moves forward |
| Q33789390 | The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attack |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
| Q34200732 | Unique proteomic signatures distinguish macrophages and dendritic cells |
| Q36867436 | VASP increases hepatic fatty acid oxidation by activating AMPK in mice. |
| Q118213492 | Valerie Z. Wall | doctoral advisor | P184 |
| Q118213614 | A Cell-Type Specific Approach to Assess the Contribution of Dysregulated Nutrient Handling to Atherosclerosis | thesis committee member | P9161 |
Search more.